GENE THERAPY FOR PROSTATE CANCER:
- 1 October 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (6) , 1220-1233
- https://doi.org/10.1097/00005392-200110000-00003
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- SUICIDE GENE THERAPY TOXICITY AFTER MULTIPLE AND REPEAT INJECTIONS IN PATIENTS WITH LOCALIZED PROSTATE CANCERJournal of Urology, 2000
- The Hallmarks of CancerCell, 2000
- Tumor-suppressive activity of CD66a in prostate cancerCancer Gene Therapy, 1999
- GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialThe Prostate, 1999
- Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancerInternational Journal of Cancer, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer ModelsHuman Gene Therapy, 1996
- Overexpression of her-2/neu in human prostate cancer and benign hyperplasiaCancer Letters, 1996
- p53, guardian of the genomeNature, 1992
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990